Shares of Quest Diagnostics Inc. DGX shed 1.45% to $151.79 Friday, on what proved to be an all-around dismal trading session ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that Adrienne L. Brott, ...

This was the stock's fifth consecutive day of gains.

Quest Diagnostics (NYSE:DGX – Get Free Report) was upgraded by Leerink Partnrs from a “hold” rating to a “strong-buy” rating ...

OhioHealth Corp. has outsourced some lab work to Quest Diagnostics Inc., part of a growing healthcare trend. Quest (NYSE:DGX) ...

Fintel reports that on January 6, 2025, Leerink Partners upgraded their outlook for Quest Diagnostics (NYSE:DGX) from Market ...

Quest Diagnostics Inc.’s DGX continued momentum in the base business is poised to help it grow in the upcoming quarters. The ongoing adoption of the highly specialized Advanced Diagnostics services is ...

Quest Diagnostics (NYSE:DGX – Get Free Report) was upgraded by Leerink Partners from a “market perform” rating to an ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $175.3, a high estimate of ...

Quest Diagnostics (DGX) announced that Adrienne Brott has been named senior vice president and chief quality and regulatory affairs officer.